IceCure’s Tumor-Freezing System Nabs FDA Breakthrough Device Status
IceCure's ProSense cryoablation system is used to treat patients with T1 invasive breast cancer or those not suited for surgical alternatives.
April 06, 2021
Israeli Firm Freezing Cancer Tumors Raises $6M In Equity Offering
IceCure Medical's cryoablation technology treats benign and malignant tumors by freezing them and turning them into ice balls.
August 09, 2020